GlycoMimetics
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
GlycoMimetics
Jul 26, 2024, 07:09 |
Blog
Harout Semerjian: I am incredibly proud to have worked alongside such passionate individuals
GlycoMimetics announced on LinkedIn: "Today, we announced we are initiating a strategic review and corporate…
Jan 8, 2024, 14:41 |
Blog
Harout Semerjian: Announcement of initial findings from our Phase 1a study of GMI-1687
Harout Semerjian, President and CEO at GlycoMimetics, shared a post by GlycoMimetics on LinkedIn: "As…
Nov 23, 2023, 15:58 |
Positive
Harout Semerjian: I'm grateful for my resilient colleagues at GlycoMimetics
Harout Semerjian, President and CEO at GlycoMimetics, shared on LinkedIn: "Happy Thanksgiving to my LinkedIn…
Oct 31, 2023, 10:23 |
Blog
Harout Semerjian: It was an honor to be appointed to the Biotechnology Innovation Organization’s Board of Directors, Emerging Companies Section
Harout Semerjian, President and CEO at GlycoMimetics, posted on LinkedIn: "It was an honor this…
Sep 28, 2023, 15:04 |
Dialogues
OncoDaily Dialogues #1 - Harout Semerjian / Hosted by Roupen Odabashian
We're thrilled to launch our new series, "OncoDaily Dialogues". This initiative by OncoDaily is designed…
Aug 21, 2023, 17:04 |
Career
Gaetano Bonifacio: I'm excited to share that I started my new role as Vice President, Global Medical Affairs at GlycoMimetics.
Gaetano Bonifacio, the Vice President of Global Medical Affairs at Glycomimetics, posted the following on…
All:
6
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube